Keywords: profits, set, fall, boehringer, ingelheim, ahead, key
Profits set to fall at Boehringer Ingelheim ahead of key product launches
Article | 14 April 2003
Privately-held German drugmaker Boehringer Ingelheim has reported arobust set of results for 2002, buoyed by a strong start from the recently-approved ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- SciClone gains China rights to Zensun's Neucardin
